Increased tacrolimus levels in a pediatric renal transplant patient attributed to chronic diarrhea
暂无分享,去创建一个
[1] Y Zhang,et al. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. , 1998, Journal of pharmaceutical sciences.
[2] L. Benet,et al. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole , 1997, Clinical pharmacology and therapeutics.
[3] S. Kawasaki,et al. Apparently increased trough levels of tacrolimus caused by acute infantile diarrhea in two infants with biliary atresia after liver transplantation , 1996, Acta paediatrica Japonica : Overseas edition.
[4] U. Christians,et al. Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber , 1996, British journal of pharmacology.
[5] Y. Yamaoka,et al. Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. , 1995, Transplantation proceedings.
[6] J. Kolars,et al. CYP3A gene expression in human gut epithelium. , 1994, Pharmacogenetics.
[7] R. Busuttil,et al. DIFFERENCES IN ORAL FK506 DOSE REQUIREMENTS BETWEEN ADULT AND PEDIATRIC LIVER TRANSPLANT PATIENTS , 1993, Transplantation.